Bryn D. Monnery

Papers

Total Citations

H-Index

About

Bryn D. Monnery is a polymer chemist whose research centers on the design and biomedical application of hydrophilic polymers, particularly poly(2-oxazoline)s (POx) and their comparison to the gold standard, poly(ethylene glycol) (PEG). His most cited work, the 2014 study "In vivo imaging of 89Zr-labeled poly(2-ethyl-2-oxazoline)s and poly(ethylene glycol)s," made a pivotal contribution by directly comparing the biodistribution and pharmacokinetics of these two polymer classes using positron emission tomography (PET). This study provided critical evidence that POx can serve as a viable alternative to PEG, offering similar stealth properties and circulation times, while potentially overcoming some of PEG’s limitations, such as immunogenicity. With 2 citations, this foundational paper has influenced subsequent research into polymer-based drug delivery and imaging agents. Monnery’s work is notable for advancing the understanding of polymer behavior in living systems, supporting the development of safer and more effective nanomedicines. His research continues to shape the field of polymer therapeutics, offering new avenues for targeted drug delivery and diagnostic imaging.